A61K 31/4245
Oxadiazoles
A61K31/4245 (Oxadiazoles) appears on 982 US grants and 1,736 published applications in this corpus.
Search patents in A61K- Granted patents
- 982
- Published applications
- 1,736
- Assignees
- 798
- Inventors
- 4,406
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 3 | 0 |
| 1999 | 7 | 0 |
| 2000 | 13 | 0 |
| 2001 | 31 | 1 |
| 2002 | 9 | 15 |
| 2003 | 6 | 29 |
| 2004 | 6 | 39 |
| 2005 | 12 | 35 |
| 2006 | 13 | 27 |
| 2007 | 13 | 33 |
| 2008 | 15 | 18 |
| 2009 | 10 | 37 |
| 2010 | 15 | 45 |
| 2011 | 10 | 42 |
| 2012 | 21 | 52 |
| 2013 | 46 | 88 |
| 2014 | 61 | 94 |
| 2015 | 78 | 97 |
| 2016 | 58 | 74 |
| 2017 | 84 | 87 |
| 2018 | 66 | 105 |
| 2019 | 69 | 109 |
| 2020 | 65 | 104 |
| 2021 | 59 | 94 |
| 2022 | 60 | 99 |
| 2023 | 44 | 90 |
| 2024 | 38 | 108 |
| 2025 | 42 | 113 |
| 2026 | 26 | 101 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- TEAD inhibitors29 Sep 2026US 12,747,207 B2Orion Corporation
- Notch signaling inhibitors for treating obesity and metabolic disorders22 Sep 2026US 12,740,989 B2Purdue Research Foundation
- PAI-1 inhibitors and uses thereof15 Sep 2026US 12,735,402 B2The Cleveland Clinic Foundation
- Small molecule antagonists for the relaxin-3/RXFP3 system15 Sep 2026US 12,735,412 B2Research Triangle Institute
- Compositions and methods for monitoring, diagnosis, detection and treatment of cancer8 Sep 2026US 12,728,115 B2GLAX Health LLC
- Methods for treating gastrointestinal inflammatory diseases using alpha-ketoglutarate (akg) modulators1 Oct 2026US 2026/0294856 A1
- Cyclic vinyl sulfone wrn inhibitors1 Oct 2026US 2026/0297070 A1Nimbus Wadjet, Inc.
- Sulfoximine compounds as histone deacetylase 6 inhibitor, and pharmaceutical composition comprising the same1 Oct 2026US 2026/0297073 A1Chong Kun Dang Pharmaceutical Corp.
- Compounds for treating rett syndrome and other disorders24 Sep 2026US 2026/0283990 A1Unravel Biosciences, Inc.
- Substituted thiophene fused derivatives, compositions comprising the same and their use as pharmaceuticals24 Sep 2026US 2026/0285829 A1Neurasic Therapeutics Inc.
Most cited
By later US patents
- Localized use of nitric oxide-adducts to prevent internal tissue damage146US 6,087,479 ANitroMed, Inc. · 2000
- Pyrazole compound and medicinal composition containing the same142US 7,429,609 B2Eisai R&D Management Co., Ltd. · 2008
- 1,2,4-oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease102US 6,992,096 B2PTC Therapeutics, Inc. · 2006
- Complement pathway modulators and uses thereof90US 9,056,874 B2Novartis AG · 2015
- CCR4 antagonists88US 7,144,903 B2Amgen Inc. · 2006